UniProt ID | RL19_HUMAN | |
---|---|---|
UniProt AC | P84098 | |
Protein Name | 60S ribosomal protein L19 | |
Gene Name | RPL19 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 196 | |
Subcellular Localization | ||
Protein Description | ||
Protein Sequence | MSMLRLQKRLASSVLRCGKKKVWLDPNETNEIANANSRQQIRKLIKDGLIIRKPVTVHSRARCRKNTLARRKGRHMGIGKRKGTANARMPEKVTWMRRMRILRRLLRRYRESKKIDRHMYHSLYLKVKGNVFKNKRILMEHIHKLKADKARKKLLADQAEARRSKTKEARKRREERLQAKKEEIIKTLSKEEETKK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSMLRLQKR ------CCHHHHHHH | 26.90 | 29514088 | |
5 | Citrullination | ---MSMLRLQKRLAS ---CCHHHHHHHHHH | 26.82 | - | |
5 | Citrullination | ---MSMLRLQKRLAS ---CCHHHHHHHHHH | 26.82 | - | |
5 | Methylation | ---MSMLRLQKRLAS ---CCHHHHHHHHHH | 26.82 | 115491861 | |
9 | Methylation | SMLRLQKRLASSVLR CHHHHHHHHHHHHHH | 23.64 | 115491851 | |
12 | Phosphorylation | RLQKRLASSVLRCGK HHHHHHHHHHHHCCC | 26.10 | 30266825 | |
13 | Phosphorylation | LQKRLASSVLRCGKK HHHHHHHHHHHCCCC | 21.40 | 30266825 | |
16 | Citrullination | RLASSVLRCGKKKVW HHHHHHHHCCCCEEE | 25.61 | - | |
16 | Citrullination | RLASSVLRCGKKKVW HHHHHHHHCCCCEEE | 25.61 | - | |
20 | Ubiquitination | SVLRCGKKKVWLDPN HHHHCCCCEEECCCC | 37.53 | - | |
21 | Acetylation | VLRCGKKKVWLDPNE HHHCCCCEEECCCCC | 41.97 | 26822725 | |
21 | Ubiquitination | VLRCGKKKVWLDPNE HHHCCCCEEECCCCC | 41.97 | 21906983 | |
29 | Phosphorylation | VWLDPNETNEIANAN EECCCCCCCHHCCCC | 44.80 | 23663014 | |
37 | Phosphorylation | NEIANANSRQQIRKL CHHCCCCHHHHHHHH | 29.11 | 19664994 | |
38 | Citrullination | EIANANSRQQIRKLI HHCCCCHHHHHHHHH | 32.03 | - | |
38 | Citrullination | EIANANSRQQIRKLI HHCCCCHHHHHHHHH | 32.03 | - | |
43 | Ubiquitination | NSRQQIRKLIKDGLI CHHHHHHHHHHCCCE | 57.08 | 21906983 | |
46 | Acetylation | QQIRKLIKDGLIIRK HHHHHHHHCCCEECC | 57.06 | 26051181 | |
46 | Ubiquitination | QQIRKLIKDGLIIRK HHHHHHHHCCCEECC | 57.06 | 21890473 | |
53 | Ubiquitination | KDGLIIRKPVTVHSR HCCCEECCCCCCCCC | 33.17 | - | |
53 | Acetylation | KDGLIIRKPVTVHSR HCCCEECCCCCCCCC | 33.17 | 26051181 | |
56 | Phosphorylation | LIIRKPVTVHSRARC CEECCCCCCCCCHHH | 22.49 | - | |
59 | Phosphorylation | RKPVTVHSRARCRKN CCCCCCCCCHHHCCC | 24.25 | 24719451 | |
67 | Phosphorylation | RARCRKNTLARRKGR CHHHCCCHHHHHCCC | 25.48 | - | |
80 | Ubiquitination | GRHMGIGKRKGTANA CCCCCCCCCCCCCCC | 49.36 | - | |
80 | Acetylation | GRHMGIGKRKGTANA CCCCCCCCCCCCCCC | 49.36 | 23954790 | |
82 | Acetylation | HMGIGKRKGTANARM CCCCCCCCCCCCCCC | 65.19 | 7668529 | |
84 | Phosphorylation | GIGKRKGTANARMPE CCCCCCCCCCCCCCH | 21.55 | - | |
92 | 2-Hydroxyisobutyrylation | ANARMPEKVTWMRRM CCCCCCHHHHHHHHH | 38.81 | - | |
92 | Ubiquitination | ANARMPEKVTWMRRM CCCCCCHHHHHHHHH | 38.81 | 21906983 | |
94 | Phosphorylation | ARMPEKVTWMRRMRI CCCCHHHHHHHHHHH | 25.31 | - | |
117 | Methylation | RESKKIDRHMYHSLY HHHCCCCHHHHHHHH | 21.68 | 115491831 | |
119 | Sulfoxidation | SKKIDRHMYHSLYLK HCCCCHHHHHHHHHH | 3.16 | 30846556 | |
120 | Phosphorylation | KKIDRHMYHSLYLKV CCCCHHHHHHHHHHE | 5.11 | 27642862 | |
122 | Phosphorylation | IDRHMYHSLYLKVKG CCHHHHHHHHHHEEC | 10.96 | 28450419 | |
124 | Phosphorylation | RHMYHSLYLKVKGNV HHHHHHHHHHEECCH | 13.90 | 27642862 | |
126 | Ubiquitination | MYHSLYLKVKGNVFK HHHHHHHHEECCHHC | 28.48 | - | |
126 | Acetylation | MYHSLYLKVKGNVFK HHHHHHHHEECCHHC | 28.48 | 26051181 | |
128 | Ubiquitination | HSLYLKVKGNVFKNK HHHHHHEECCHHCCH | 43.08 | 21906983 | |
128 | Acetylation | HSLYLKVKGNVFKNK HHHHHHEECCHHCCH | 43.08 | 26210075 | |
133 | Ubiquitination | KVKGNVFKNKRILME HEECCHHCCHHHHHH | 58.22 | 21906983 | |
135 | Ubiquitination | KGNVFKNKRILMEHI ECCHHCCHHHHHHHH | 41.21 | - | |
139 | Sulfoxidation | FKNKRILMEHIHKLK HCCHHHHHHHHHHHH | 3.07 | 30846556 | |
144 | Methylation | ILMEHIHKLKADKAR HHHHHHHHHHHHHHH | 51.59 | 72631043 | |
144 | Ubiquitination | ILMEHIHKLKADKAR HHHHHHHHHHHHHHH | 51.59 | 21890473 | |
144 | 2-Hydroxyisobutyrylation | ILMEHIHKLKADKAR HHHHHHHHHHHHHHH | 51.59 | - | |
144 | Malonylation | ILMEHIHKLKADKAR HHHHHHHHHHHHHHH | 51.59 | 26320211 | |
144 | Acetylation | ILMEHIHKLKADKAR HHHHHHHHHHHHHHH | 51.59 | 25953088 | |
146 | Ubiquitination | MEHIHKLKADKARKK HHHHHHHHHHHHHHH | 60.38 | - | |
152 | Ubiquitination | LKADKARKKLLADQA HHHHHHHHHHHHHHH | 53.27 | 21890473 | |
152 | Acetylation | LKADKARKKLLADQA HHHHHHHHHHHHHHH | 53.27 | 25953088 | |
153 | 2-Hydroxyisobutyrylation | KADKARKKLLADQAE HHHHHHHHHHHHHHH | 43.08 | - | |
153 | Ubiquitination | KADKARKKLLADQAE HHHHHHHHHHHHHHH | 43.08 | 21890473 | |
153 | Malonylation | KADKARKKLLADQAE HHHHHHHHHHHHHHH | 43.08 | 26320211 | |
162 | Methylation | LADQAEARRSKTKEA HHHHHHHHHHHHHHH | 34.60 | 115491841 | |
164 | Phosphorylation | DQAEARRSKTKEARK HHHHHHHHHHHHHHH | 38.84 | 28985074 | |
165 | Ubiquitination | QAEARRSKTKEARKR HHHHHHHHHHHHHHH | 62.90 | - | |
167 | Methylation | EARRSKTKEARKRRE HHHHHHHHHHHHHHH | 53.78 | 116252551 | |
180 | Acetylation | REERLQAKKEEIIKT HHHHHHHHHHHHHHH | 47.99 | 23749302 | |
180 | Ubiquitination | REERLQAKKEEIIKT HHHHHHHHHHHHHHH | 47.99 | 19608861 | |
181 | Sumoylation | EERLQAKKEEIIKTL HHHHHHHHHHHHHHH | 64.69 | 25114211 | |
181 | Acetylation | EERLQAKKEEIIKTL HHHHHHHHHHHHHHH | 64.69 | 26051181 | |
181 | Ubiquitination | EERLQAKKEEIIKTL HHHHHHHHHHHHHHH | 64.69 | 21890473 | |
186 | 2-Hydroxyisobutyrylation | AKKEEIIKTLSKEEE HHHHHHHHHHCHHHH | 49.42 | - | |
186 | Acetylation | AKKEEIIKTLSKEEE HHHHHHHHHHCHHHH | 49.42 | 26051181 | |
186 | Ubiquitination | AKKEEIIKTLSKEEE HHHHHHHHHHCHHHH | 49.42 | 21906983 | |
187 | Phosphorylation | KKEEIIKTLSKEEET HHHHHHHHHCHHHHH | 26.34 | 27794612 | |
189 | Phosphorylation | EEIIKTLSKEEETKK HHHHHHHCHHHHHCC | 43.16 | 23401153 | |
190 | Ubiquitination | EIIKTLSKEEETKK- HHHHHHCHHHHHCC- | 72.72 | 1906983 | |
190 | Acetylation | EIIKTLSKEEETKK- HHHHHHCHHHHHCC- | 72.72 | 23749302 | |
190 | 2-Hydroxyisobutyrylation | EIIKTLSKEEETKK- HHHHHHCHHHHHCC- | 72.72 | - | |
194 | Phosphorylation | TLSKEEETKK----- HHCHHHHHCC----- | 47.62 | 23403867 | |
195 | Ubiquitination | LSKEEETKK------ HCHHHHHCC------ | 60.82 | 21906983 | |
196 | Ubiquitination | SKEEETKK------- CHHHHHCC------- | 73.35 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RL19_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RL19_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-80, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13 AND THR-187, AND MASSSPECTROMETRY. |